Meeting
2023 ASCO Annual Meeting
A randomized phase III clinical trial of acupuncture for chemotherapy-induced peripheral neuropathy in survivors of cancer.
Authors
Ivana Lopez-Nieves
Memorial Sloan Kettering Cancer Center, New York, NY
Ivana Lopez-Nieves , Christopher Chiang , Katherine Han , Lauren Piulson , Christina Seluzicki , Matthew Weitzman , Yi Lily Zhang , Iris Zhi , Ting Bao
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Late and Long-Term Adverse Effects
Clinical Trial Registration Number
NCT04917796
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr TPS12144)
DOI
10.1200/JCO.2023.41.16_suppl.TPS12144
Abstract #
TPS12144
Poster Bd #
508b
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
A randomized phase III clinical trial of acupuncture for chemotherapy-induced peripheral neuropathy (CIPN) in cancer survivors.
First Author: Andee Dooley
Poster
2022 ASCO Annual Meeting
A randomized phase III clinical trial of yoga for chemotherapy-induced peripheral neuropathy treatment.
First Author: Katherine Han
First Author: Marco Santos Teles
Poster
2024 ASCO Genitourinary Cancers Symposium
Patient reported outcomes (PROs) among patients with metastatic castration-resistant prostate cancer (mCRPC) by homologous recombination repair mutations (HRRm) gene clusters: Findings from the phase 3 TALAPRO-2 study cohort 2.
First Author: Karim Fizazi